Loading the map…
Other professional, scientific and technical activities n.e.c. · Cambridge
Synexus Clinical Research
Synexus Clinical Research Limited
Private limited company registered in Cambridge, classed under “Other professional, scientific and technical activities n.e.c.”.
Headline figures
FY to Dec 2022 · Company only
Turnover
For subscribers
Profit after tax
−£9.15m
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
4 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2020 | 2021 | 2022 |
|---|---|---|---|
| Profit after tax | −£9.15m | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees | |||
| Retained reserves |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2020 | 2021 | 2022 |
|---|---|---|---|
| Fixed assets | |||
| Current assets | |||
| of which debtors | |||
| of which cash | |||
| Creditors due within a year | |||
| Net current assets | |||
| Net assets | |||
| Ratios | |||
| Profit marginProfit after tax as a share of turnover | |||
| Current ratioCurrent assets for every £1 owed within a year | |||
| Cash ratioCash for every £1 owed within a year | |||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | |||
| Turnover per employeeTurnover divided by average staff | |||
| Debtor daysDays of turnover owed by customers at the year end | |||
7 balance-sheet lines and 6 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-18
- AccountsFull accounts made up to 31 December 2025
- DirectorsTermination of appointment of Rhona Gregg as a secretary on 31 March 2026
- SharesStatement of capital on 30 January 2026 · GBP 0.20 (and 2 more like it since 31 August 2016)
- SharesStatement by Directors (and 1 more like it since 31 August 2016)
- NoticeSolvency Statement dated 22/12/25
- FilingResolutions (and 4 more like it since 13 June 2016)
- SharesStatement of capital following an allotment of shares on 12 December 2025 · GBP 0.2
- AccountsFull accounts made up to 31 December 2024
- AccountsFull accounts made up to 31 December 2023
- DirectorsAppointment of Georgina Adams Green as a director on 18 April 2024
- DirectorsAppointment of Alison Jane Starr as a director on 18 April 2024
- DirectorsTermination of appointment of David John Norman as a director on 18 April 2024
26 earlier
- AccountsFull accounts made up to 31 December 2022
- DirectorsTermination of appointment of Julia Mary James as a director on 24 May 2023
- DirectorsAppointment of David John Norman as a director on 29 March 2023
- DirectorsTermination of appointment of Jason James Berg as a director on 29 March 2023
- DirectorsTermination of appointment of Richard Stuart Harris as a director on 29 March 2023
- DirectorsAppointment of Syed Waqas Ahmed as a director on 29 March 2023
- DirectorsAppointment of Euan Daney Ross Cameron as a director on 29 March 2023
- DirectorsAppointment of Anthony Hugh Smith as a director on 29 March 2023
- DirectorsAppointment of Jason James Berg as a director on 31 January 2023
- DirectorsTermination of appointment of Dustin Nathan Owen as a director on 31 January 2023
- AccountsFull accounts made up to 31 December 2021
- DirectorsAppointment of Oakwood Corporate Secretary Limited as a secretary on 29 November 2022
- DirectorsAppointment of Rhona Gregg as a secretary on 29 November 2022
- DirectorsDirector's details changed for Dustin Nathan Owen on 22 September 2021
- AddressRegister(s) moved to registered inspection location
- AddressRegister inspection address has been changed (and 1 more like it since 3 July 2020)
- OwnershipChange of details for Synexus Clinical Research Midco No 1 Limited as a person with significant control on 1 September 2021
- AccountsFull accounts made up to 31 December 2020
- AddressRegistered office address changed from 12B Granta Park Great Abington Cambridge CB21 6GQ England to 12B Granta Park Great Abington Cambridge CB21 6GQ on 1 September 2021
- AddressRegistered office address changed from Sandringham House Ackhurst Park Chorley Lancashire PR7 1NY to 12B Granta Park Great Abington Cambridge CB21 6GQ on 1 September 2021
- DirectorsAppointment of Mr Richard Stuart Harris as a director on 30 June 2021
- DirectorsAppointment of Dustin Nathan Owen as a director on 30 June 2021
- DirectorsTermination of appointment of Jill Marie Pellegrino as a director on 30 June 2021
- DirectorsTermination of appointment of Riaan Van Tonder as a director on 30 June 2021
- AccountsFull accounts made up to 31 December 2019
- DirectorsTermination of appointment of Roger Dale Smith as a director on 30 June 2020
- Accounts
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Synexus Clinical Research do?
Private limited company registered in Cambridge, classed under “Other professional, scientific and technical activities n.e.c.”.
›How much turnover does Synexus Clinical Research make?
Answered in the full report
›Is Synexus Clinical Research profitable?
No: it made a loss after tax of £9.15m in the year to 31 December 2022, its latest filed accounts.
›How many people work at Synexus Clinical Research?
Answered in the full report
›Who runs and owns Synexus Clinical Research?
Its directors are Oakwood Corporate Secretary Limited, Syed Waqas Ahmed, Euan Daney Ross Cameron, Georgina Adams Green, Anthony Hugh Smith and 1 more. Its owners are shown to subscribers.
›Where is Synexus Clinical Research based?
Its registered office is 12b Granta Park, Great Abington, Cambridge, CB21 6GQ, in Cambridge.
›When was Synexus Clinical Research founded?
Synexus Clinical Research Limited was incorporated on 27 September 2005.
›Is Synexus Clinical Research still trading?
The register lists Synexus Clinical Research Limited as active.